Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: EC:2.7.11.22 (
cdc2
)
8,319
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Extra centrosomes are found in many tumors, and their appearance is an early event that can generate aberrant mitotic spindles and aneuploidy. Because the failure to appropriately degrade the Mps1 protein kinase correlates with centrosome overproduction in tumor-derived cells, defects in the factors that promote Mps1 degradation may contribute to extra centrosomes in tumors. However, while we have recently characterized an Mps1 degradation signal, the factors that regulate Mps1 centrosomal Mps1 are unknown. Antizyme (
OAZ
), a mediator of ubiquitin-independent degradation and a suspected tumor suppressor, was recently shown to localize to centrosomes and modulate centrosome overproduction, but the known
OAZ
substrates were not responsible for its effect on centrosomes. We have found that
OAZ
exerts its effect on centrosomes via Mps1.
OAZ
promotes the removal of Mps1 from centrosomes, and centrosome overproduction caused by reducing
OAZ
activity requires Mps1.
OAZ
binds to Mps1 via the Mps1 degradation signal and modulates the function of Mps1 in centrosome overproduction. Moreover,
OAZ
regulates the canonical centrosome duplication cycle, and reveals a function for Mps1 in procentriole assembly. Together, our data suggest that
OAZ
restrains the assembly of centrioles by controlling the levels of centrosomal Mps1 through the
Cdk2
-regulated Mps1 degradation signal.
...
PMID:Antizyme restrains centrosome amplification by regulating the accumulation of Mps1 at centrosomes. 2086 9